Clorox Company — Form 10-Q Summary
Business context and reporting period. Clorox is a multinational consumer and professional products company operating through Cleaning, Household, Lifestyle and International segments. This unaudited filing covers the quarter and six months ended December 31, 2016 (fiscal Q2 and first half of fiscal 2017); comparisons are with the corresponding 2015 periods.
Financial performance and position
| Metric | Three months ended Dec. 31 | Six months ended Dec. 31 |
|---|---|---|
| Net sales | $1.406 billion, up 5% | $2.849 billion, up 4% |
| Gross profit / margin | $629 million / 44.7%, versus 44.6% | $1.269 billion / 44.5%, versus 44.8% |
| Earnings from continuing operations | $150 million, versus $151 million | $329 million, versus $324 million |
| Net earnings | $149 million, unchanged | $328 million, versus $321 million |
| Diluted EPS from continuing operations | $1.14, unchanged | $2.51, up from $2.46 |
| Net cash provided by continuing operations | Not presented for the quarter | $271 million, versus $178 million |
For the six-month period, capital expenditures were $117 million versus $68 million; cash dividends paid were $206 million versus $198 million, and share repurchases were $183 million versus $144 million. Cash and cash equivalents were $414 million at December 31, 2016. Total debt was $2.549 billion, comprising $759 million of notes and loans payable, $400 million of current maturities and $1.390 billion of long-term debt. Current assets were $1.549 billion and current liabilities were $2.037 billion.
Clorox had no borrowings under its $1.1 billion revolving credit agreement, with $24 million available under foreign and other credit lines. Its reported covenant leverage ratio was 2.02 against a maximum of 3.50; the company said it was compliant and anticipated continued compliance.
Material changes and segment results
- Sales volume rose 8% in both the quarter and six-month period. Volume growth exceeded sales growth, reflecting unfavorable foreign exchange and product mix, partly offset by price increases. RenewLife, acquired in May 2016 for $290 million, contributed to Household and International results.
- Quarterly segment sales were Cleaning $469 million (+3%), Household $421 million (+12%), Lifestyle $260 million (+4%) and International $256 million (-2%). Cleaning earnings before tax declined 15% to $104 million; Household increased 6% to $71 million; Lifestyle increased 7% to $77 million; International increased 27% to $28 million.
- Quarterly gross margin improved 10 basis points on cost savings and pricing, partly offset by higher manufacturing and logistics costs. Six-month gross margin declined 30 basis points, with higher manufacturing and logistics costs and unfavorable mix outweighing savings and pricing.
- Quarterly diluted EPS from continuing operations was flat as sales growth and savings were offset by manufacturing and logistics costs and the Aplicare impairment. Six-month EPS increased 2%, with similar offsets.
- Six-month operating cash flow from continuing operations increased primarily because of higher earnings excluding non-cash items and lower tax payments. Higher manufacturing-efficiency spending drove the increase in capital expenditures.
Outlook, commentary, risks and unusual items
- The filing provides no specific numerical sales, earnings or EPS guidance. Management noted that interim results are not necessarily indicative of full-year results.
- A $21 million non-cash impairment charge was recorded for Aplicare assets following a December 2016 FDA warning letter concerning sterilization-process validation, quality controls and environmental monitoring. Aplicare represented slightly less than 1% of company sales; further charges may arise as Clorox responds to the letter and considers strategic alternatives.
- Environmental liabilities were $22 million at December 31, 2016, up from $14 million at June 30, 2016. The company recorded $9 million for a California site; regulators could require another evaluated remediation option costing up to $28 million over an estimated 30-year period, or require other actions. Additional exposure at a Michigan site is reasonably possible but not estimable.
- Clorox estimated it could incur a further $0–$10 million in after-tax Venezuela exit costs through fiscal 2019; cumulative exit costs were $50 million. Venezuela’s operations remain discontinued.
- Management highlighted risks including competition, commodity and transportation cost inflation, customer concentration, foreign-exchange volatility and international political or regulatory conditions. Argentina’s peso declined 6% during the six months; Clorox cautioned that further currency volatility could adversely affect results. Walmart and affiliates accounted for 26% of sales.
- The six-month effective tax rate fell to 33.0% from 34.5%, primarily due to tax benefits from adopting new share-based compensation accounting guidance. Management reported effective disclosure controls and no material change in internal control over financial reporting during the quarter.
Investor verification points
- Assess how much of sales and volume growth reflects underlying demand versus RenewLife acquisition contributions, pricing, product mix and foreign exchange.
- Track whether manufacturing and logistics cost pressure persists and whether cost savings sustain margins, particularly in Cleaning and Household.
- Review Aplicare’s regulatory response, remaining assets of $17 million and any additional impairment or operating costs.
- Monitor remediation requirements and estimates for the California and Michigan environmental matters, including potential exposure beyond recorded liabilities.
- Evaluate debt maturities, commercial-paper dependence, covenant headroom and the company’s capacity to sustain dividends and repurchases.
- Follow currency, inflation and political developments in Argentina and other international markets, and the potential remaining costs of the Venezuela exit.